The human blood system contains many different cell types with different functions. The cells in the blood are typically broken down into three types: red blood cells or erythrocytes, white blood cells or leukocytes, and platelets or thrombocytes. The white blood cells or leukocytes are distinguished from the other types of blood cells in that they have a nucleus. These types of cells have become an area of great interest for disease prevention, including cancer, in recent scientific investigations.
The leukocytes are typically broken down into two types of cells: granulocytes and agranulocytes. The differentiation between these two cell types is the presence of granules in their cytoplasm. The cell types are also distinguished by the shapes of their nucleus as to whether the nucleus is lobed into three segments or non-lobed. One area of great interest recently is a subset of the agranulocytes, which are also known as mononuclear leukocytes, which contains lymphocytes, monocytes and macrophages. The lymphocytes are more common in the lymphatic system, which is part of the circulatory system and a vital part of the immune system, comprising a network of lymphatic vessels that carry a clear fluid called lymph directionally towards the heart. The leukocytes may be further broken down into three main types of cells: B cells, T cells and natural killer cells (NK cells).
T cells, named as such because they mature in the thymus, have been found to play an intricate role in the immune system and disease prevention. For instance, one special type of T cell is known as a Jurkat T cell. This is an immortalized line of cells that are used to study T cell leukemia, T cell signaling, and other types of diseases, particularly HIV.
To study these Jurkat T cells, it is necessary to filter and separate the cells from cell cultures. Various means are utilized for the separation process including centrifugation and physical filter (size exclusion) processes. During these physical separation processes, many of the cells are damaged or destroyed.
It is therefore desirable to utilize a separation and filtration process that does not damage the cells of interest for scientific investigation. In this regard, acoustophoresis is the separation of particles and secondary fluids from a primary or host fluid using high intensity acoustic standing waves, and without the use of membranes or physical size exclusion filters.
The present disclosure relates, in various embodiments, to acoustophoretic systems, devices, and methods using multi-dimensional acoustic standing waves to separate particles from a particle/fluid mixture, namely biological cells (e.g., Chinese hamster ovary (CHO) cells, NSO hybridoma cells, baby hamster kidney (BHK) cells, or human cells, T cells, B cells, NK cells, algae, bacteria, viruses, or microcarriers) from a host fluid. More particularly, the devices include a flow chamber to which is coupled an ultrasonic transducer that can be actuated to set up a multi-dimensional acoustic standing wave. The ultrasonic transducer may be used with a reflector to generate the multi-dimensional acoustic standing wave. Two opposing ultrasonic transducers may be used to generate the multi-dimensional acoustic standing wave. An ultrasonic transducer may be used to generate an acoustic wave, as well as to reflect an acoustic wave, which can contribute to generating the multi-dimensional acoustic standing wave
Disclosed herein in various embodiments are methods for separating biological cells from a host fluid, comprising: chilling a mixture of the host fluid and the biological cells; and flowing the cooled mixture of the host fluid and the biological cells through a first acoustophoretic device. The first acoustophoretic device comprises: a flow chamber having at least one inlet and at least one outlet; at least one ultrasonic transducer coupled to the flow chamber to permit a multi-dimensional acoustic standing wave to be generated in the flow chamber by the at least one ultrasonic transducer. The at least one ultrasonic transducer includes a piezoelectric material configured to be driven to create a multi-dimensional acoustic standing wave in the flow chamber. A reflector across the flow chamber from the at least one ultrasonic transducer is provided to reflect an ultrasonic signal to contribute to generating the multi-dimensional acoustic standing wave in the flow chamber. A first signal is sent to the first acoustophoretic device to drive the at least one ultrasonic transducer to create the multi-dimensional standing wave. At least some of the biological cells are trapped in the standing wave, and then agglomerate, aggregate, clump, or coalesce together, and subsequently settle out of the host fluid due to enhanced gravitational settling forces. The settled clusters may exit the flow chamber via the at least one outlet.
The biological cells can be Jurkat T cells, or can be T cells having a low ribosomal content of less than 30 wt % (dry mass fraction of the cell).
During the chilling step, the mixture can be chilled to a temperature of about 20° C. to about 25° C. Alternatively, the chilling can lower the temperature of the mixture by from about 10° C. to about 20° C.
In specific embodiments, the at least one outlet of the device includes a concentrate outlet that is located at a bottom end of the flow chamber for recovering the biological cells; and the first acoustophoretic device also includes a permeate outlet located at a top end of the flow chamber. In some such embodiments, the host fluid and biological cells exiting the permeate outlet of the first acoustophoretic device can be sent to an inlet of a second acoustophoretic device. This is a “dual-pass” acoustophoretic system.
The mixture may be flowed into the first acoustophoretic device at a flow rate such that the mixture has a residence of at least 5 minutes. In particular embodiments, the concentrated fluid/cell mixture recovered from the at least one concentrate outlet (i) has a cell concentration of at least two times an original cell concentration of the mixture of the host fluid and the biological cells; and (ii) has a volume of at least one half an original feed volume of the mixture of the host fluid and the biological cells.
Also disclosed herein are acoustophoretic systems for separating biological cells from a mixture of a host fluid and the biological cells, comprising: a means for chilling the mixture; and a first acoustophoretic device. The first acoustophoretic device comprises: a flow chamber having at least one inlet and at least one outlet, the at least one inlet being fluidly connected to the means for chilling; at least one ultrasonic transducer coupled to a side of the flow chamber, the at least one ultrasonic transducer including a piezoelectric material that can be driven to create a multi-dimensional acoustic standing wave in the flow chamber; and a reflector coupled to an opposite side of the flow chamber from the at least one ultrasonic transducer.
The means for chilling the mixture may be a pre-chiller or a fan. This chilling means aids in reducing outgassing that may occur.
In particular embodiments, the at least one inlet of the first acoustophoretic device may be a dump diffuser. Generally, the dump diffuser is used to make the incoming flow more uniform by reducing non-uniformities in the flow chamber resulting from gravity forces, so that the efficiency of the acoustophoretic device is increased or maximized.
The at least one outlet can include a concentrate outlet that is located at a first end of the flow chamber, and the first acoustophoretic device may further include a permeate outlet located at a second end of the flow chamber opposite the first end.
In additional embodiments, the system further comprises a second acoustophoretic device that is generally of the same structure as the first acoustophoretic device, except that the at least one inlet of the second acoustophoretic device is fluidly connected to the permeate outlet of the first acoustophoretic device.
In certain embodiments, a transparent viewing window may be located on a side of the flow chamber opposite the at least one inlet.
Dual-pass acoustophoretic systems for separating biological cells from a mixture of a host fluid and the biological cells are also disclosed. In this way, the acoustophoretic devices of the present disclosure can be incorporated into acoustophoretic systems in which the devices are arranged in series to create a filter “train.” The systems can therefore be considered dual- or multi-pass/multi-stage systems. The use of multiple stages of acoustic filtration reduces the burden on subsequent filtration stages and provides for (i) better clarification of the fluid and (ii) better separation of cells from the fluid. This permits recovery of the cells and/or the clarified fluid, as desired.
These and other non-limiting characteristics are more particularly described below.
The following is a brief description of the drawings, which are presented for the purposes of illustrating the exemplary embodiments disclosed herein and not for the purposes of limiting the same.
The present disclosure may be understood more readily by reference to the following detailed description of desired embodiments and the examples included therein. In the following specification and the claims which follow, reference will be made to a number of terms which shall be defined to have the following meanings.
Although specific terms are used in the following description for the sake of clarity, these terms are intended to refer only to the particular structure of the embodiments selected for illustration in the drawings, and are not intended to define or limit the scope of the disclosure. In the drawings and the following description below, it is to be understood that like numeric designations refer to components of like function.
The singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.
The term “comprising” is used herein as requiring the presence of the named component and allowing the presence of other components. The term “comprising” should be construed to include the term “consisting of”, which allows the presence of only the named component, along with any impurities that might result from the manufacture of the named component.
Numerical values should be understood to include numerical values which are the same when reduced to the same number of significant figures and numerical values which differ from the stated value by less than the experimental error of conventional measurement technique of the type described in the present application to determine the value.
All ranges disclosed herein are inclusive of the recited endpoint and independently combinable (for example, the range of “from 2 grams to 10 grams” is inclusive of the endpoints, 2 grams and 10 grams, and all the intermediate values). The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value; they are sufficiently imprecise to include values approximating these ranges and/or values.
The modifier “about” used in connection with a quantity is inclusive of the stated value and has the meaning dictated by the context. When used in the context of a range, the modifier “about” should also be considered as disclosing the range defined by the absolute values of the two endpoints. For example, the range of “from about 2 to about 10” also discloses the range “from 2 to 10.” The term “about” may refer to plus or minus 10% of the indicated number. For example, “about 10%” may indicate a range of 9% to 11%, and “about 1” may mean from 0.9-1.1.
It should be noted that many of the terms used herein are relative terms. For example, the terms “upper” and “lower” are relative to each other in location, i.e. an upper component is located at a higher elevation than a lower component in a given orientation, but these terms can change if the device is flipped. The terms “inlet” and “outlet” are relative to a fluid flowing through them with respect to a given structure, e.g. a fluid flows through the inlet into the structure and flows through the outlet out of the structure. The terms “upstream” and “downstream” are relative to the direction in which a fluid flows through various components, i.e. the flow fluids through an upstream component prior to flowing through the downstream component. It should be noted that in a loop, a first component can be described as being both upstream of and downstream of a second component.
The terms “horizontal” and “vertical” are used to indicate direction relative to an absolute reference, i.e. ground level. However, these terms should not be construed to require structures to be absolutely parallel or absolutely perpendicular to each other. For example, a first vertical structure and a second vertical structure are not necessarily parallel to each other. The terms “top” and “bottom” or “base” are used to refer to surfaces where the top is always higher than the bottom/base relative to an absolute reference, i.e. the surface of the earth. The terms “upwards” and “downwards” are also relative to an absolute reference; upwards is always against the gravity of the earth.
The term “parallel” should be construed in its lay sense of two surfaces that maintain a generally constant distance between them, and not in the strict mathematical sense that such surfaces will never intersect when extended to infinity.
The present application refers to “the same order of magnitude.” Two numbers are of the same order of magnitude if the quotient of the larger number divided by the smaller number is a value that is at least 1 and less than 10.
Acoustophoresis is a low-power, no-pressure-drop, no-clog, solid-state approach to particle removal from fluid dispersions: i.e., it is used to achieve separations that are more typically performed with porous filters, but it has none of the disadvantages of filters. In particular, the acoustophoretic devices of the present disclosure are suitable for use with bioreactors and operate at the macro-scale for separations in flowing systems with high flow rates. The acoustophoretic devices are designed to create a high intensity multi-dimensional ultrasonic standing wave that results in an acoustic radiation force that is larger than the combined effects of fluid drag and buoyancy or gravity, and is therefore able to trap (i.e., hold stationary) the suspended phase (i.e. cells) to allow more time for the acoustic wave to increase particle concentration, agglomeration and/or coalescence. This is an important distinction from previous approaches where particle trajectories were merely altered by the effect of the acoustic radiation force. As a result, in the present devices, the radiation force acts as a filter that prevents targeted particles (e.g., biological cells) from crossing the plane of the standing wave. The trapping capability of a standing wave may be varied as desired, for example by varying the flow rate of the fluid, the acoustic radiation force, and the shape of the acoustophoretic device to maximize cell retention through trapping and settling. This technology offers a green and sustainable alternative for separation of secondary phases with a significant reduction in cost of energy. Excellent particle separation efficiencies have been demonstrated for particle sizes as small as one micron. The acoustophoretic devices of the present disclosure have the ability to create ultrasonic standing wave fields that can trap particles in flow fields with a linear velocity ranging from 0.1 mm/sec to velocities exceeding 1 cm/s.
Generally, an acoustic standing wave generates pressure minima at locations on the standing wave where the amplitude is minimum and maximum. These are called, respectively, nodes and anti-nodes. These pressure minima nodes and anti-nodes may be utilized to capture materials that are differentiated from the surrounding environment by size, density and compressibility (i.e., the speed of sound through the material). Those materials that collect at the pressure minima nodes are known as having a positive contrast factor. Those materials that collect at the pressure minima anti-nodes are known as having a negative contrast factor.
In a typical experiment, the system is operated such that the particles are trapped in the ultrasonic standing wave, i.e., remain in a stationary position. The axial component of the acoustic radiation force drives the particles, with a positive contrast factor, to the pressure nodal planes, whereas particles with a negative contrast factor are driven to the pressure anti-nodal planes. The radial or lateral component of the acoustic radiation force contributes to trapping the particle. The forces acting on the particle may be greater than the combined effect of fluid drag force and gravitational force. For small particles or emulsions, the drag force FD can be expressed as:
where Uf and Up are the fluid and particle velocity, Rp is the particle radius, μf and μp are the dynamic viscosity of the fluid and particle, and {circumflex over (μ)}=μp/μf is the ratio of dynamic viscosities. The buoyancy force FB is expressed as:
FB=4/3πRp3(ρf−ρp)g (2)
where Rp is the particle radius, ρf is the fluid density, ρp is the particle density, and g is the universal gravitational constant.
For a particle to be trapped in the ultrasonic standing wave, the force balance on the particle can be assumed to be zero, and therefore an expression for lateral acoustic radiation force FLRF can be found, which is given by:
FLRF=FD+FB (3)
For a particle of known size and material property, and for a given flow rate, this equation can be used to estimate the magnitude of the lateral acoustic radiation force.
The theoretical model that is used to calculate the acoustic radiation force is the formulation developed by Gor'kov, where the primary acoustic radiation force FR is defined as a function of a field potential U, FR=−∇(U), where the field potential U is defined as
and f1 and f2 are the monopole and dipole contributions defined by
where p is the acoustic pressure, u is the fluid particle velocity, ^ is the ratio of cell density ρp to fluid density ρf, σ is the ratio of cell sound speed cp to fluid sound speed cf, Vo=πRp3 is the volume of the cell, and < > indicates time averaging over the period of the wave.
For a one dimensional standing wave, where the acoustic pressure is expressed as
p=A cos(kx)cos(ωt) (7)
where A is the acoustic pressure amplitude, k is the wavenumber, and w is the angular frequency. In this case, there is only the axial component of the acoustic radiation force FARF, which is found to be
where X is the contrast factor given by
Particles with a positive contrast factor will be driven to the pressure nodal planes, and particles with a negative contrast factor will be driven to the pressure anti-nodal planes. In this way, the generation of a multi-dimensional acoustic standing wave in a flow chamber results in the creation of tightly packed clusters of particles in the flow chamber, typically corresponding to the location of the pressure nodes or anti-nodes in the standing wave depending on acoustic contrast factor.
Gork'ov's model is for a single particle in a standing wave and is limited to particle sizes that are small with respect to the wavelength of the sound fields in the fluid and the particle. It also does not take into account the effect of viscosity of the fluid and the particle on the radiation force. As a result, this model cannot be used for the macro-scale ultrasonic separators discussed herein since particle clusters can grow quite large. A more complex and complete model for acoustic radiation forces without any restriction as to particle size relative to wavelength was therefore used. The models that were implemented are based on the theoretical work of Yurii Ilinskii and Evgenia Zabolotskaya as described in AIP Conference Proceedings, Vol. 1474-1, pp. 255-258 (2012) and “Acoustic radiation force of a sphere without restriction to axisymmetric fields,” Proceedings of Meetings on Acoustics, Vol. 19, 045004 (2013). These models also include the effect of fluid and particle viscosity, and therefore are a more accurate calculation of the acoustic radiation force.
The density of a cell type is typically dependent upon the organelles that are enclosed within the cell wall. One type of organelle, the ribosome, is particularly dense. High concentration of ribosomes in cells can thus allow for a high contrast factor between the cell and its fluid medium, and thus allow for excellent differentiation and separation by an acoustic standing wave. However, cells with low ribosomal content of less than 30 wt % (dry mass fraction of the cell), such as Jurkat T cells, present a lower contrast factor and thus can be harder to distinguish, acoustically, from the fluid medium in which they are carried.
Cells that have a low contrast factor compared to the fluid in which they are transported are more difficult to separate using an acoustic standing wave. Through specialized perturbations of a piezoelectric material, higher order modes of vibration in the piezoelectric material may be generated. When this piezoelectric material that is perturbed in a multimode fashion is coupled with a reflector, a specialized type of acoustic standing wave, known as a multi-dimensional acoustic standing wave, is generated. In this way, Jurkat T cells may be separated from a fluid medium utilizing a multi-dimensional acoustic standing wave. The Jurkat T cells are generally at lower concentrations than, for example, a CHO cell population with 30 million cells per mL versus a concentration of 1 million cells per mL for the Jurkat T cells. Thus, the low contrast cells, such as Jurkat T cells, in a low population concentration are separated continuously from the fluid media within which they are entrained by utilizing a multi-dimensional acoustic standing wave.
The lateral force of the total acoustic radiation force (ARF) generated by the ultrasonic transducers of the present disclosure is significant and is sufficient to overcome the fluid drag force at linear velocities of up to 1 cm/s and beyond. This lateral ARF can thus be used to continuously trap cells in the standing wave, thereby causing the cells to agglomerate, aggregate, clump, or coalesce together, and subsequently settle out of the fluid due to enhanced gravitational forces or rise out of the fluid due to enhanced buoyancy. This lateral ARF can also be used to retain cells in a bioreactor while the bioreactor process continues, which is especially true for a perfusion bioreactor. Additionally, as explained above, this action of the acoustic forces (i.e., lateral and axial acoustic forces) on the trapped particles results in formation of tightly packed clusters through concentration, agglomeration and/or coalescence of particles that settle through enhanced gravity (particles heavier than the host fluid) or buoyancy (particles lighter than the host fluid). Relatively large solids of one material can thus be separated from smaller particles of a different material, the same material, and/or the host fluid through enhanced gravitational separation.
The multi-dimensional standing wave generates acoustic radiation forces in both the axial direction (i.e., in the direction of the standing wave, between the transducer and the reflector, perpendicular to the flow direction) and the lateral direction (i.e., in the flow direction). As the mixture flows through the flow chamber, particles in suspension experience a strong axial force component in the direction of the standing wave. Since this acoustic force is perpendicular to the flow direction and the drag force, it quickly moves the particles to pressure nodal planes or anti-nodal planes, depending on the contrast factor of the particle. The lateral acoustic radiation force then acts to move the concentrated particles towards the center of each planar node, resulting in agglomeration or clumping. The lateral acoustic radiation force component can overcome fluid drag for such clumps of particles to continually grow and then drop out of the mixture due to gravity. Therefore, both the drop in drag per particle as the particle cluster increases in size, as well as the drop in acoustic radiation force per particle as the particle cluster grows in size, may be considered in determining the effectiveness of the acoustic separator device. In the present disclosure, the lateral force component and the axial force component of the multi-dimensional acoustic standing wave are of the same order of magnitude. In this regard, it is noted that in a multi-dimensional acoustic standing wave, the axial force is stronger than the lateral force, but the lateral force of a multi-dimensional acoustic standing wave is much higher than the lateral force of a planar standing wave, usually by two orders of magnitude or more.
With reference now to
The acoustophoretic device 100 includes a flow chamber 110 having at least one inlet and at least one outlet. In the embodiment depicted in
The flow chamber 110 is the region of the device 100 through which is flowed an initial mixture of a host fluid and the biological cells. In the embodiment shown in
As depicted in
In the embodiment depicted in
In the embodiment depicted in
The host fluid/biological cell mixture should be flowed into the device 100 at a flow rate such that the mixture has a residence time of at least 5 minutes, or at least 10 minutes. Desirably, the concentrated cell/fluid mixture recovered from the concentrate outlet has a final cell concentration of at least two times the original cell concentration of the original mixture of the host fluid and the biological cells. Desirably, the concentrated cell/fluid mixture recovered from the concentrate outlet also has a volume of at least one half the original feed volume of the original mixture of the host fluid and the biological cells. Put another way, the volume reduction factor (volume of concentrated mixture divided by the volume of the original mixture) is at least two (2), and in further embodiments may be at least four (4).
Turning now to
The first and second acoustophoretic devices 100, 200 are very similar to each other. In particular, each acoustophoretic device includes a flow chamber having an inlet, a first outlet (i.e. concentrate outlet), a second outlet (i.e. permeate outlet), an ultrasonic transducer, and a reflector. Device 100 includes flow chamber 110 having inlet 112, permeate outlet 114, concentrate outlet 116, ultrasonic transducer 120, and a reflector (not shown), and is depicted in
The frequency/power of the multi-dimensional acoustic standing wave(s) generated by each individual ultrasonic transducer of the system may be varied to capture cells of different sizes, or they may be operated at the same frequency so that the downstream ultrasonic transducer(s) capture additional biological cells that were not captured by an upstream ultrasonic transducer. This permits recovery of the cells and/or the clarified fluid, as desired. In particular embodiments, each transducer in the system is operated at a frequency of about 0.5 megahertz (MHz) to about 4 MHz, including from about 1 MHz to about 2.5 MHz, and from about 2 MHz to about 2.5 MHz.
Prior to discussing further optimization of the devices, it is helpful to provide an explanation now of how multi-dimensional acoustic standing waves are generated. The multi-dimensional acoustic standing wave needed for particle collection is obtained by driving an ultrasonic transducer composed of a piezoelectric material at a frequency that both generates the acoustic standing wave and excites a fundamental 3D vibration mode of the piezoelectric material. The transducer may be composed of various materials that may be perturbed to generate an ultrasonic wave. For example, the transducer may be composed of a piezoelectric material, including a piezoelectric crystal or poly-crystal. Perturbation of the piezoelectric material in an ultrasonic transducer in a multimode fashion allows for generation of a multidimensional acoustic standing wave. A piezoelectric material can be specifically designed to deform in a multimode fashion at designed frequencies, allowing for generation of a multi-dimensional acoustic standing wave. The multi-dimensional acoustic standing wave may be generated by distinct modes of the piezoelectric material such as a 3×3 mode that would generate multidimensional acoustic standing waves. A multitude of multidimensional acoustic standing waves may also be generated by allowing the piezoelectric material to vibrate through many different mode shapes. Thus, the piezoelectric material would excite multiple modes such as a 0×0 mode (i.e. a piston mode) to a 1×1, 2×2, 1×3, 3×1, 3×3, and other higher order modes and then cycle back through the lower modes of the piezoelectric material (not necessarily in straight order). This switching or dithering of the piezoelectric material between modes allows for various multidimensional wave shapes, along with a single piston mode shape to be generated over a designated time.
Some further explanation of the ultrasonic transducers used in the devices, systems, and methods of the present disclosure may be helpful as well. In this regard, the transducers may be composed of a piezoelectric material, such as a piezoelectric crystal or poly-crystal, usually made of PZT-8 (lead zirconate titanate). Such crystals may have a 1 inch diameter and a nominal 2 MHz resonance frequency, and may also be of a larger size. Each ultrasonic transducer module can have only one crystal, or can have multiple crystals that each act as a separate ultrasonic transducer and are either controlled by one or multiple amplifiers. The piezoelectric material can be square, rectangular, irregular polygon, or generally of any arbitrary shape. The transducer(s) is/are used to create a pressure field that generates forces of the same order of magnitude both orthogonal to the standing wave direction (lateral) and in the standing wave direction (axial).
The transducer can be driven by a signal, such as a voltage signal, a current signal, a magnetic signal, an electromagnetic signal, a capacitive signal, or any other type of signal to which the transducer is responsive to create a multi-dimensional acoustic standing wave in the acoustic chamber. The multi-dimensional acoustic standing wave may be formed with one or more secondary transducers that have an active portion that is directed to another transducer to generate an acoustic standing wave through their interactive operation. For example, the frequency, phase, amplitude or other parameters of the transducers may be controlled to cooperatively generate an acoustic standing wave therebetween. Such an acoustic standing wave may result from constructive/destructive interference between the acoustic waves generated by the respective transducers.
Screws 88 attach an aluminum top plate 82a of the housing to the body 82b of the housing via threads. The top plate includes a connector 84 for powering the transducer. The top surface of the PZT crystal 86 is connected to a positive electrode 90 and a negative electrode 92, which are separated by an insulating material 94. The electrodes can be made from any conductive material, such as silver or nickel. Electrical power is provided to the PZT crystal 86 through the electrodes on the crystal. Note that the crystal 86 has no backing layer or epoxy layer. Put another way, there is an air gap 87 in the transducer between aluminum top plate 82a and the crystal 86 (i.e. the air gap is completely empty). A minimal backing 58 (on the interior surface) and/or wear plate 50 (on the exterior surface) may be provided in some embodiments, as seen in
The transducer design can affect performance of the system. A typical transducer is a layered structure with the ceramic crystal bonded to a backing layer and a wear plate. Because the transducer is loaded with the high mechanical impedance presented by the standing wave, the traditional design guidelines for wear plates, e.g., half wavelength thickness for standing wave applications or quarter wavelength thickness for radiation applications, and manufacturing methods may not be appropriate. Rather, in one embodiment of the present disclosure the transducers, there is no wear plate or backing, allowing the crystal to vibrate in one of its eigenmodes (i.e. near eigenfrequency) with a high Q-factor. The vibrating ceramic crystal/disk is directly exposed to the fluid flowing through the flow chamber.
Removing the backing (e.g. making the crystal air backed) also permits the ceramic crystal to vibrate at higher order modes of vibration with little damping (e.g. higher order modal displacement). In a transducer having a crystal with a backing, the crystal vibrates with a more uniform displacement, like a piston. Removing the backing allows the crystal to vibrate in a non-uniform displacement mode. The higher order the mode shape of the crystal, the more nodal lines the crystal has. The higher order modal displacement of the crystal creates more trapping lines, although the correlation of trapping line to node is not necessarily one to one, and driving the piezoelectric material/crystal at a higher frequency will not necessarily produce more trapping lines.
In some embodiments, the crystal may have a backing that minimally affects the Q-factor of the crystal (e.g. less than 5%). The backing may be made of a substantially acoustically transparent material such as balsa wood, foam, or cork which allows the crystal to vibrate in a higher order mode shape and maintains a high Q-factor while still providing some mechanical support for the crystal. The backing layer may be a solid, or may be a lattice having holes through the layer, such that the lattice follows the nodes of the vibrating crystal in a particular higher order vibration mode, providing support at node locations while allowing the rest of the crystal to vibrate freely. The goal of the lattice work or acoustically transparent material is to provide support without lowering the Q-factor of the crystal or interfering with the excitation of a particular mode shape.
Placing the crystal in direct contact with the fluid also contributes to the high Q-factor by avoiding the dampening and energy absorption effects of the epoxy layer and the wear plate. Other embodiments may have wear plates or a wear surface to prevent the PZT, which contains lead, contacting the host fluid. This may be desirable in, for example, biological applications such as separating blood. Such applications might use a wear layer such as chrome, electrolytic nickel, or electroless nickel. Chemical vapor deposition could also be used to apply a layer of poly(p-xylylene) (e.g. Parylene) or other polymers or polymer films. Organic and biocompatible coatings such as silicone or polyurethane are also usable as a wear surface.
Initially, when a suspension is flowing through the system with primarily small micron sized particles, it is necessary for the acoustic radiation force to balance the combined effect of fluid drag force and buoyancy force for a particle to be trapped in the standing wave. In
Particle size growth continues until the buoyancy force becomes dominant, which is indicated by a second critical particle size, Rc2. The buoyancy force per unit volume of the cluster remains constant with cluster size, since it is a function of the particle density, cluster concentration and gravity constant. Therefore, as the cluster size increases, the buoyancy force on the cluster increases faster than the acoustic radiation force. At the size Rc2, the particles will rise or sink, depending on their relative density with respect to the host fluid. At this size, acoustic forces are secondary, gravity/buoyancy forces become dominant, and the particles naturally drop out or rise out of the host fluid. Not all particles will drop out, and those remaining particles and new particles entering the flow chamber will continue to move to the three-dimensional nodal locations, repeating the growth and drop-out process. This phenomenon explains the quick drops and rises in the acoustic radiation force beyond size Rc2. Thus,
The size, shape, and thickness of the transducer determine the transducer displacement at different frequencies of excitation, which in turn affects particle separation efficiency. Higher order modal displacements generate three-dimensional acoustic standing waves with strong gradients in the acoustic field in all directions, thereby creating equally strong acoustic radiation forces in all directions, leading to multiple trapping lines, where the number of trapping lines correlate with the particular mode shape of the transducer.
To investigate the effect of the transducer displacement profile on acoustic trapping force and particle separation efficiencies, an experiment was repeated ten times, with all conditions identical except for the excitation frequency. Ten consecutive acoustic resonance frequencies, indicated by circled numbers 1-9 and letter A on
As the emulsion passed by the transducer, the trapping lines of oil droplets were observed and characterized. The characterization involved the observation and pattern of the number of trapping lines across the fluid channel, as shown in
The effect of excitation frequency clearly determines the number of trapping lines, which vary from a single trapping line at the excitation frequency of acoustic resonance 5 and 9, to nine trapping lines for acoustic resonance frequency 4. At other excitation frequencies four or five trapping lines are observed. Different displacement profiles of the transducer can produce different (more) trapping lines in the standing waves, with more gradients in displacement profile generally creating higher trapping forces and more trapping lines. It is noted that although the different trapping line profiles shown in
This device 510 includes a dump diffuser, plenum inlet configuration (i.e., the at least one inlet is a dump diffuser). Where more than one inlet is desired, a second inlet can be provided on the side of the flow chamber opposite the first inlet 530, such that the device would include a symmetrical, dual dump diffuser construction. In such a construction, two dump diffusers 530 would be placed on opposite sides of the device. In
The dump diffuser eliminates downward flow in the flow chamber. The mixture fills up the plenum in the dump diffuser and then flows horizontally into the flow chamber, where the mixture flows vertically upwards past the multi-dimensional acoustic standing wave(s). The dump diffuser reduces/eliminates flow pulsations and flow non-uniformities that result from pumps, hosing and horizontal inlet flow where gravity effects dominate. The dump diffuser brings the heavier mixture into the flow chamber below the ultrasonic transducer and the nodal clusters that form in the ultrasonic standing waves. This minimizes any disturbances of the clusters set up by inflowing material.
As previously explained, when a dual dump diffuser construction is desired, the device may be symmetrical about a vertical plane or line of symmetry. This vertical plane or line of symmetry is aligned with gravity forces. Also shown in
As the particle clusters drop out, the axial acoustic forces associated with the standing wave will keep the clusters intact. This assures rapid dropping of the clusters with high terminal velocities, on the order of 1 cm/sec. This is extremely fast compared to the chamber flow velocities, which are on the order of 0.1 cm/sec to 0.3 cm/sec. The shallow wall angle means the cylindrical particle clusters have to drop only a very short distance before they exit the flow chamber, so that little dispersion of the clusters occurs. Ideally, the system operates with 3 to 12 crystal vibration nodes per square inch of transducer. The symmetry, minimum flow disturbance in the central collection region, and shallow collector walls provide good collection without the need for baffles/laminar plates.
One specific application for the acoustophoretic devices disclosed herein is in the processing of bioreactor materials. It is important to be able to separate certain cells, such as Jurkat T cells, from other cells in the cell culture. Through the use of acoustophoresis, the separation of the different cell types is very efficient and leads to very little loss of the desired cell types. This is an improvement over current filtration processes (depth filtration, tangential flow filtration, and the like), which show limited efficiencies at high cell densities. The use of acoustophoresis aids in greatly increasing the yield of the bioreactor.
It is contemplated that the acoustophoretic systems/devices of the present disclosure can be used in a filter “train,” in which multiple different filtration steps are used to clarify or purify an initial fluid/particle mixture to obtain the desired product and manage different materials from each filtration step. Each filtration step can be optimized to remove a particular material, improving the overall efficiency of the clarification process. An individual acoustophoretic device can operate as one or multiple filtration steps. For example, each individual ultrasonic transducer within a particular acoustophoretic device can be operated to trap materials within a given particle range. It is particularly contemplated that the acoustophoretic device can be used to remove large quantities of material, reducing the burden on subsequent downstream filtration steps/stages. However, it is contemplated that additional filtration steps/stages can be placed upstream or downstream of the acoustophoretic device. Multiple acoustophoretic devices can be used as well. It is particularly contemplated that desirable biomolecules or cells can be recovered/separated after such filtration/purification.
The outlets of the acoustophoretic devices of the present disclosure (e.g. clarified fluid and concentrated cells) can be fluidly connected to any other filtration step or filtration stage. Such filtration steps can include various methods such as depth filtration, sterile filtration, size exclusion filtration, or tangential filtration. Depth filtration uses physical porous filtration mediums that can retain material through the entire depth of the filter. In sterile filtration, membrane filters with extremely small pore sizes are used to remove microorganisms and viruses, generally without heat or irradiation or exposure to chemicals. Size exclusion filtration separates materials by size and/or molecular weight using physical filters with pores of given size. In tangential filtration, the majority of fluid flow is across the surface of the filter, rather than into the filter.
Chromatography can also be used, including cationic chromatography columns, anionic chromatography columns, affinity chromatography columns, mixed bed chromatography columns. Other hydrophilic/hydrophobic processes can also be used for filtration purposes.
The following examples are provided to illustrate the devices and methods of the present disclosure. The examples are merely illustrative and are not intended to limit the disclosure to the materials, conditions, or process parameters set forth therein.
In
A yeast mixture was used in which the mixture was 250 mL of yeast in PBS diluted to 1.00×106 cells/mL. The first outlet 116 had no flow, as the device was drained at the conclusion of testing (i.e. after all of the mixture was run through the device).
For the study depicted in the photographs of
For the study depicted in the photographs of
In total, three tests were run with the yeast mixture flowed through the device at a flow rate of 5 mL/minute (
For the studies depicted in the photographs of
For the study depicted in the photographs of
In
For the study depicted in the photograph of
For the study depicted in the photograph of
The results for the first device 100 and the second device 200 of the multi-pass acoustophoretic system 700 were combined, and a summary of the performance of the system 300 is provided in the table below.
As can be seen from the table summarizing the performance of the system 300, the dual-pass acoustophoretic system 300 yielded a retention of 74% and a volume reduction factor of 2.6 times (i.e. original feed volume divided final concentrate volume).
The present disclosure has been described with reference to exemplary embodiments. Modifications and alterations may occur to others upon reading and understanding the preceding detailed description. It is intended that the present disclosure be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
This application claims priority to U.S. Provisional Patent Application Ser. No. 62/286,984, filed on Jan. 26, 2016. This application is also a continuation-in-part of U.S. patent application Ser. No. 15/139,248, filed on Apr. 26, 2016, which was a continuation-in-part of U.S. patent application Ser. No. 14/975,307, filed Dec. 18, 2015, which claims priority to U.S. Provisional Patent Application Ser. No. 62/256,952, filed on Nov. 18, 2015, and to U.S. Provisional Patent Application Ser. No. 62/243,211, filed on Oct. 19, 2015, and to U.S. Provisional Patent Application Ser. No. 62/211,057, filed on Aug. 28, 2015, and to U.S. Provisional Patent Application Ser. No. 62/093,491, filed on Dec. 18, 2014. U.S. patent application Ser. No. 14/975,307 is also a continuation-in-part of U.S. patent application Ser. No. 14/175,766, filed on Feb. 7, 2014, which claims priority to U.S. Provisional Patent Application Ser. No. 61/761,717, filed on Feb. 7, 2013, and is also a continuation-in-part of U.S. patent application Ser. No. 14/026,413, filed on Sep. 13, 2013, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/708,641, filed on Oct. 2, 2012. U.S. patent application Ser. No. 14/026,413 is also a continuation-in-part of U.S. Ser. No. 13/844,754, filed Mar. 15, 2013, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/754,792, filed Jan. 21, 2013, and of U.S. Provisional Patent Application Ser. No. 61/708,641, filed Oct. 2, 2012, and of U.S. Provisional Patent Application Ser. No. 61/611,159, filed Mar. 15, 2012, and of U.S. Provisional Patent Application Ser. No. 61/611,240, filed Mar. 15, 2012. These applications are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
2473971 | Ross | Jun 1949 | A |
2667944 | Crites | Feb 1954 | A |
3372370 | Cyr | Mar 1968 | A |
3555311 | Weber | Jan 1971 | A |
4055491 | Porath-Furedi | Oct 1977 | A |
4065875 | Srna | Jan 1978 | A |
4118649 | Schwartzman et al. | Oct 1978 | A |
4158629 | Sawyer | Jun 1979 | A |
4165273 | Azarov et al. | Aug 1979 | A |
4173725 | Asai et al. | Nov 1979 | A |
4204096 | Barcus et al. | May 1980 | A |
4254661 | Kossoff et al. | Mar 1981 | A |
4320659 | Lynnworth et al. | Mar 1982 | A |
4344448 | Potts | Aug 1982 | A |
4398325 | Piaget et al. | Aug 1983 | A |
4552669 | Sekellick | Nov 1985 | A |
4666595 | Graham | May 1987 | A |
4673512 | Schram | Jun 1987 | A |
4699588 | Zinn et al. | Oct 1987 | A |
4743361 | Schram | May 1988 | A |
4759775 | Peterson et al. | Jul 1988 | A |
4800316 | Wang | Jan 1989 | A |
4821838 | Chen | Apr 1989 | A |
4836684 | Javorik et al. | Jun 1989 | A |
4860993 | Goode | Aug 1989 | A |
4878210 | Mitome | Oct 1989 | A |
4983189 | Peterson et al. | Jan 1991 | A |
5059811 | King et al. | Oct 1991 | A |
5062965 | Bernou et al. | Nov 1991 | A |
5085783 | Feke et al. | Feb 1992 | A |
5164094 | Stuckart | Nov 1992 | A |
5225089 | Benes et al. | Jul 1993 | A |
5371729 | Manna | Dec 1994 | A |
5395592 | Bolleman et al. | Mar 1995 | A |
5431817 | Braatz et al. | Jul 1995 | A |
5443985 | Lu et al. | Aug 1995 | A |
5452267 | Spevak | Sep 1995 | A |
5475486 | Paoli | Dec 1995 | A |
5484537 | Whitworth | Jan 1996 | A |
5527460 | Trampler et al. | Jun 1996 | A |
5560362 | Sliwa, Jr. et al. | Oct 1996 | A |
5594165 | Madanshetty | Jan 1997 | A |
5604301 | Mountford et al. | Feb 1997 | A |
5626767 | Trampler et al. | May 1997 | A |
5688405 | Dickinson et al. | Nov 1997 | A |
5711888 | Trampler et al. | Jan 1998 | A |
5831166 | Kozuka et al. | Nov 1998 | A |
5834871 | Puskas | Nov 1998 | A |
5902489 | Yasuda et al. | May 1999 | A |
5912182 | Coakley et al. | Jun 1999 | A |
5947299 | Vazquez et al. | Sep 1999 | A |
5951456 | Scott | Sep 1999 | A |
6090295 | Raghavarao et al. | Jun 2000 | A |
6166231 | Hoeksema | Dec 2000 | A |
6216538 | Yasuda et al. | Apr 2001 | B1 |
6205848 | Faber et al. | Jun 2001 | B1 |
6273262 | Yasuda et al. | Aug 2001 | B1 |
6332541 | Coakley et al. | Dec 2001 | B1 |
6391653 | Letcher et al. | May 2002 | B1 |
6475151 | Koger et al. | Nov 2002 | B2 |
6482327 | Mod et al. | Nov 2002 | B1 |
6487095 | Malik et al. | Nov 2002 | B1 |
6592821 | Wada et al. | Jul 2003 | B1 |
6641708 | Becker et al. | Nov 2003 | B1 |
6649069 | DeAngelis | Nov 2003 | B2 |
6699711 | Hahn et al. | Mar 2004 | B1 |
6727451 | Fuhr et al. | Apr 2004 | B1 |
6763722 | Fjield et al. | Jul 2004 | B2 |
6881314 | Wang et al. | Apr 2005 | B1 |
6929750 | Laurell et al. | Aug 2005 | B2 |
6936151 | Lock et al. | Aug 2005 | B1 |
7008540 | Weavers et al. | Mar 2006 | B1 |
7010979 | Scott | Mar 2006 | B2 |
7061163 | Nagahara et al. | Jun 2006 | B2 |
7081192 | Wang et al. | Jul 2006 | B1 |
7093482 | Berndt | Aug 2006 | B2 |
7108137 | Lal et al. | Sep 2006 | B2 |
7150779 | Meegan, Jr. | Dec 2006 | B2 |
7186502 | Vesey | Mar 2007 | B2 |
7191787 | Redeker et al. | Mar 2007 | B1 |
7322431 | Ratcliff | Jan 2008 | B2 |
7331233 | Scott | Feb 2008 | B2 |
7340957 | Kaduchak et al. | Mar 2008 | B2 |
7373805 | Hawkes et al. | May 2008 | B2 |
7541166 | Belgrader et al. | Jun 2009 | B2 |
7601267 | Haake et al. | Oct 2009 | B2 |
7673516 | Janssen et al. | Mar 2010 | B2 |
7837040 | Ward et al. | Nov 2010 | B2 |
7846382 | Strand et al. | Dec 2010 | B2 |
7968049 | Takahashi et al. | Jun 2011 | B2 |
8075786 | Bagajewicz | Dec 2011 | B2 |
8080202 | Takahashi et al. | Dec 2011 | B2 |
8134705 | Kaduchak et al. | Mar 2012 | B2 |
8256076 | Feller | Sep 2012 | B1 |
8266950 | Kaduchak et al. | Sep 2012 | B2 |
8273253 | Curran | Sep 2012 | B2 |
8273302 | Takahashi et al. | Sep 2012 | B2 |
8309408 | Ward et al. | Nov 2012 | B2 |
8319398 | Vivek et al. | Nov 2012 | B2 |
8334133 | Fedorov et al. | Dec 2012 | B2 |
8387803 | Thorslund et al. | Mar 2013 | B2 |
8592204 | Lipkens et al. | Nov 2013 | B2 |
8679338 | Rietman et al. | Mar 2014 | B2 |
8691145 | Dionne et al. | Apr 2014 | B2 |
8873051 | Kaduchak et al. | Oct 2014 | B2 |
8889388 | Wang et al. | Nov 2014 | B2 |
9272234 | Lipkens et al. | Mar 2016 | B2 |
9357293 | Claussen | May 2016 | B2 |
9365815 | Miyazaki et al. | Jun 2016 | B2 |
9368110 | Hershey et al. | Jun 2016 | B1 |
9388363 | Goodson et al. | Jul 2016 | B2 |
9391542 | Wischnewskiy | Jul 2016 | B2 |
9403114 | Kusuura | Aug 2016 | B2 |
9410256 | Dionne et al. | Aug 2016 | B2 |
9416344 | Lipkens et al. | Aug 2016 | B2 |
9421553 | Dionne et al. | Aug 2016 | B2 |
9422328 | Kennedy, III et al. | Aug 2016 | B2 |
9457139 | Ward et al. | Oct 2016 | B2 |
9457302 | Lipkens et al. | Oct 2016 | B2 |
9458450 | Lipkens et al. | Oct 2016 | B2 |
9464303 | Burke | Oct 2016 | B2 |
9476855 | Ward et al. | Oct 2016 | B2 |
9480375 | Marshall et al. | Nov 2016 | B2 |
9480935 | Mariella, Jr. et al. | Nov 2016 | B2 |
9488621 | Kaduchak et al. | Nov 2016 | B2 |
9504780 | Spain et al. | Nov 2016 | B2 |
9512395 | Lipkens et al. | Dec 2016 | B2 |
9513205 | Yu et al. | Dec 2016 | B2 |
9514924 | Morris et al. | Dec 2016 | B2 |
9517474 | Mao et al. | Dec 2016 | B2 |
20020038662 | Schuler et al. | Apr 2002 | A1 |
20020134734 | Campbell et al. | Sep 2002 | A1 |
20030015035 | Kaduchak et al. | Jan 2003 | A1 |
20030028108 | Miller et al. | Feb 2003 | A1 |
20030195496 | Maguire | Oct 2003 | A1 |
20030209500 | Kock et al. | Nov 2003 | A1 |
20030230535 | Affeld et al. | Dec 2003 | A1 |
20040016699 | Bayevsky | Jan 2004 | A1 |
20040035208 | Diaz et al. | Feb 2004 | A1 |
20040112841 | Scott | Jun 2004 | A1 |
20040124155 | Meegan, Jr. | Jul 2004 | A1 |
20040149039 | Cardelius | Aug 2004 | A1 |
20050031499 | Meier | Feb 2005 | A1 |
20050121269 | Namduri | Jun 2005 | A1 |
20050145567 | Quintel et al. | Jul 2005 | A1 |
20050196725 | Fu | Sep 2005 | A1 |
20060037915 | Strand et al. | Feb 2006 | A1 |
20060037916 | Trampler | Feb 2006 | A1 |
20060050615 | Swisher | Mar 2006 | A1 |
20070053795 | Laugharn, Jr. et al. | Mar 2007 | A1 |
20070224676 | Haq | Sep 2007 | A1 |
20070267351 | Roach et al. | Nov 2007 | A1 |
20070272618 | Gou et al. | Nov 2007 | A1 |
20070284299 | Xu et al. | Dec 2007 | A1 |
20080011693 | Li et al. | Jan 2008 | A1 |
20080067128 | Hoyos et al. | Mar 2008 | A1 |
20080105625 | Rosenberg et al. | May 2008 | A1 |
20080181838 | Kluck | Jul 2008 | A1 |
20080217259 | Siversson | Sep 2008 | A1 |
20080245709 | Kaduchak et al. | Oct 2008 | A1 |
20080245745 | Ward et al. | Oct 2008 | A1 |
20080264716 | Kuiper et al. | Oct 2008 | A1 |
20080272034 | Ferren et al. | Nov 2008 | A1 |
20080272065 | Johnson | Nov 2008 | A1 |
20080316866 | Goodemote et al. | Dec 2008 | A1 |
20090029870 | Ward et al. | Jan 2009 | A1 |
20090048805 | Kaduchak et al. | Feb 2009 | A1 |
20090053686 | Ward et al. | Feb 2009 | A1 |
20090087492 | Johnson et al. | Apr 2009 | A1 |
20090098027 | Tabata et al. | Apr 2009 | A1 |
20090104594 | Webb | Apr 2009 | A1 |
20090126481 | Burris | May 2009 | A1 |
20090178716 | Kaduchak et al. | Jul 2009 | A1 |
20090194420 | Mariella, Jr. et al. | Aug 2009 | A1 |
20090227042 | Gauer et al. | Sep 2009 | A1 |
20090045107 | Ward et al. | Dec 2009 | A1 |
20090295505 | Mohammadi et al. | Dec 2009 | A1 |
20100000945 | Gavalas | Jan 2010 | A1 |
20100078323 | Takahashi et al. | Apr 2010 | A1 |
20100078384 | Yang | Apr 2010 | A1 |
20100124142 | Laugharn et al. | May 2010 | A1 |
20100139377 | Huang et al. | Jun 2010 | A1 |
20100192693 | Mudge et al. | Aug 2010 | A1 |
20100193407 | Steinberg et al. | Aug 2010 | A1 |
20100206818 | Leong et al. | Aug 2010 | A1 |
20100255573 | Bond et al. | Oct 2010 | A1 |
20100261918 | Chianelli et al. | Oct 2010 | A1 |
20100317088 | Radaelli et al. | Dec 2010 | A1 |
20100323342 | Gonzalez Gomez et al. | Dec 2010 | A1 |
20100330633 | Walther et al. | Dec 2010 | A1 |
20110003350 | Schafran et al. | Jan 2011 | A1 |
20110024335 | Ward et al. | Feb 2011 | A1 |
20110092726 | Clarke | Apr 2011 | A1 |
20110095225 | Eckelberry et al. | Apr 2011 | A1 |
20110123392 | Dionne et al. | May 2011 | A1 |
20110125024 | Mueller | May 2011 | A1 |
20110146678 | Ruecroft et al. | Jun 2011 | A1 |
20110154890 | Holm et al. | Jun 2011 | A1 |
20110166551 | Schafer | Jul 2011 | A1 |
20110189732 | Weinand et al. | Aug 2011 | A1 |
20110245750 | Lynch et al. | Oct 2011 | A1 |
20110262990 | Wang et al. | Oct 2011 | A1 |
20110278218 | Dionne et al. | Nov 2011 | A1 |
20110281319 | Swayze et al. | Nov 2011 | A1 |
20110309020 | Rietman et al. | Dec 2011 | A1 |
20120088295 | Yasuda et al. | Apr 2012 | A1 |
20120145633 | Polizzotti et al. | Jun 2012 | A1 |
20120163126 | Campbell et al. | Jun 2012 | A1 |
20120175012 | Goodwin et al. | Jul 2012 | A1 |
20120231504 | Niazi | Sep 2012 | A1 |
20120267288 | Chen et al. | Oct 2012 | A1 |
20120325727 | Dionne et al. | Dec 2012 | A1 |
20120325747 | Reitman et al. | Dec 2012 | A1 |
20120328477 | Dionne et al. | Dec 2012 | A1 |
20120329122 | Lipkens et al. | Dec 2012 | A1 |
20130017577 | Arunakumari et al. | Jan 2013 | A1 |
20130115664 | Khanna et al. | May 2013 | A1 |
20130175226 | Coussios et al. | Jul 2013 | A1 |
20130217113 | Srinivasan et al. | Aug 2013 | A1 |
20130277316 | Dutra et al. | Oct 2013 | A1 |
20130277317 | LoRicco et al. | Oct 2013 | A1 |
20130284271 | Lipkens et al. | Oct 2013 | A1 |
20140011240 | Lipkens et al. | Jan 2014 | A1 |
20140017758 | Kniep et al. | Jan 2014 | A1 |
20140102947 | Baym et al. | Apr 2014 | A1 |
20140141413 | Laugham, Jr. et al. | May 2014 | A1 |
20140319077 | Lipkens et al. | Oct 2014 | A1 |
20140377834 | Presz, Jr. et al. | Dec 2014 | A1 |
20150053561 | Ward et al. | Feb 2015 | A1 |
20150060581 | Santos et al. | Mar 2015 | A1 |
20150321129 | Lipkens et al. | Nov 2015 | A1 |
20160121331 | Kapur et al. | May 2016 | A1 |
20160123858 | Kapur et al. | May 2016 | A1 |
20160145563 | Berteau et al. | May 2016 | A1 |
20160153249 | Mitri | Jun 2016 | A1 |
20160175198 | Warner et al. | Jun 2016 | A1 |
20160184790 | Sinha et al. | Jun 2016 | A1 |
20160202237 | Zeng et al. | Jul 2016 | A1 |
20160208213 | Doyle et al. | Jul 2016 | A1 |
20160230168 | Kaduchak et al. | Aug 2016 | A1 |
20160237110 | Gilmanshin et al. | Aug 2016 | A1 |
20160237394 | Lipkens et al. | Aug 2016 | A1 |
20160237395 | Lipkens et al. | Aug 2016 | A1 |
20160252445 | Yu et al. | Sep 2016 | A1 |
20160279540 | Presz, Jr. et al. | Sep 2016 | A1 |
20160279551 | Foucault | Sep 2016 | A1 |
20160312168 | Pizzi | Oct 2016 | A1 |
20160314868 | El-Zahab et al. | Oct 2016 | A1 |
20160319270 | Lipkens et al. | Nov 2016 | A1 |
20160325206 | Presz, Jr. et al. | Nov 2016 | A1 |
20160332159 | Dual et al. | Nov 2016 | A1 |
20160339360 | Lipkens et al. | Nov 2016 | A1 |
20160347628 | Dionne et al. | Dec 2016 | A1 |
20160355776 | Lipkens et al. | Dec 2016 | A1 |
20160361670 | Lipkens et al. | Dec 2016 | A1 |
20160363579 | Lipkens et al. | Dec 2016 | A1 |
20180298371 | Lipkens | Oct 2018 | A1 |
Number | Date | Country |
---|---|---|
30 27 433 | Feb 1982 | DE |
32 18 488 | Nov 1983 | DE |
196 48 519 | Jun 1998 | DE |
103 19 467 | Jul 2004 | DE |
10 2008 006 501 | Sep 2008 | DE |
0 292 470 | Nov 1988 | EP |
0 641 606 | Mar 1995 | EP |
1 175 931 | Jan 2002 | EP |
1 254 669 | Nov 2002 | EP |
2 420 510 | May 2006 | GB |
9-136090 | May 1997 | JP |
2085933 | Jul 1997 | RU |
629496 | Oct 1978 | SU |
WO 198707178 | Dec 1987 | WO |
WO 8911899 | Dec 1989 | WO |
WO 9005008 | Mar 1990 | WO |
WO 9734643 | Sep 1997 | WO |
WO 1998017373 | Apr 1998 | WO |
WO 9850133 | Nov 1998 | WO |
WO 02072234 | Sep 2002 | WO |
WO 03089567 | Oct 2003 | WO |
WO 2004079716 | Sep 2004 | WO |
WO 2009063198 | May 2009 | WO |
WO 2009111276 | Sep 2009 | WO |
WO 2009144709 | Dec 2009 | WO |
WO 2010024753 | Apr 2010 | WO |
WO 2010040394 | Apr 2010 | WO |
WO 2011023949 | Mar 2011 | WO |
WO 2011025890 | Mar 2011 | WO |
WO 2011027146 | Mar 2011 | WO |
WO 2011131947 | Oct 2011 | WO |
WO 2011161463 | Dec 2011 | WO |
WO 2013043297 | Mar 2013 | WO |
WO 2013055517 | Apr 2013 | WO |
WO 2013138797 | Sep 2013 | WO |
WO 2013148376 | Oct 2013 | WO |
WO 2013159014 | Oct 2013 | WO |
WO 2014014941 | Jan 2014 | WO |
WO 2014029505 | Feb 2014 | WO |
WO 2014055219 | Apr 2014 | WO |
WO 2014124306 | Aug 2014 | WO |
WO 2014153651 | Oct 2014 | WO |
WO 2015006730 | Jan 2015 | WO |
Entry |
---|
Grenvall et al.; Concurrent Isolation of Lymphocytes and Granulocytes Using Prefocused Free Flow Acoustophoresis; Analytical Chemistry; vol. 87; pp. 5596-5604; 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2017/015197 dated Apr. 3, 2017. |
Alvarez et al.; Shock Waves, vol. 17, No. 6, pp. 441-447, 2008. |
Benes et al.; Ultrasonic Separation of Suspended Particles, 2001 IEEE Ultrasonics Symposium; Oct. 7-10, 2001; pp. 649-659; Atlanta, Georgia. |
Castilho et al.; Animal Cell Technology: From Biopharmaceuticals to Gene Therapy; 11—Animal Cell Separation; 2008. |
Castro; Tunable gap and quantum quench dynamics in bilayer graphene; Jul. 13, 2010; Mathematica Summer School. |
Cravotto et al.; Ultrasonics Sonochemistry, vol. 15, No. 5, pp. 898-902, 2008. |
Garcia-Lopez, et al; Enhanced Acoustic Separation of Oil-Water Emulsion in Resonant Cavities. The Open Acoustics Journal. 2008, vol. 1, pp. 66-71. |
Hill et al.; Ultrasonic Particle Manipulation; Microfluidic Technologies for Miniaturized Analysis Systems, Jan. 2007, pp. 359-378. |
Ilinskii et al.; Acoustic Radiation Force on a Sphere in Tissue; AIP Conference Proceedings; 2012. |
Kuznetsova et al.; Microparticle concentration in short path length ultrasonic resonators: Roles of radiation pressure and acoustic streaming; Journal of the Acoustical Society of America, American Institute of Physics for the Acoustical Society of America, vol. 116, No. 4, Oct. 1, 2004, pp. 1956-1966, DOI: 1.1121/1.1785831. |
Latt et al.; Ultrasound-membrane hybrid processes for enhancement of filtration properties; Ultrasonics sonochemistry 13.4 (2006): 321-328. |
Li et al.; Electromechanical behavior of PZT-brass unimorphs; J. Am. Ceram. Soc. vol. 82; No. 7; pp. 1733-1740, 1999. |
Lipkens et al.; Frequency sweeping and fluid flow effects on particle trajectories in ultrasonic standing waves; Acoustics 08, Paris, Jun. 29-Jul. 4, 2008. |
Lipkens et al.; Prediction and measurement of particle velocities in ultrasonic standing waves; J. Acoust. Soc. Am., 124 No. 4, pp. 2492 (A) 2008. |
Lipkens et al.; Separation of micron-sized particles in macro-scale cavities by ultrasonic standing waves; Presented at the International Congress on Ultrasonics, Santiago; Jan. 11-17, 2009. |
Lipkens et al.; The effect of frequency sweeping and fluid flow on particle trajectories in ultrasonic standing waves; IEEE Sensors Journal, vol. 8, No. 6, pp. 667-677, 2008. |
Lipkens et al.; Separation of bacterial spores from flowering water in macro-scale cavities by ultrasonic standing waves; submitted/uploaded to http://arxiv.org/abs/1006.5467 on Jun. 28, 2010. |
Lipkens et al., Macro-scale acoustophoretic separation of lipid particles from red blood cells, The Journal of the Acoustical Society of America, vol. 133, Jun. 2, 2013, p. 045017, XP055162509, New York, NY. |
Meribout et a.; An Industrial-Prototype Acoustic Array for Real-Time Emulsion Layer Detection in Oil Storage Tanks; IEEE Sensors Journal, vol. 9, No. 12, Dec. 2009. |
Nilsson et al.; Review of cell and particle trapping in microfluidic systems; Department of Measurement Technology and Industrial Electrical Engineering, Div. of Nanobiotechnology, Lund University, P.O. Box 118. Lund, Sweden, Analytica Chimica Acta 649, Jul. 14, 2009, pp. 141-157. |
Pangu et al.; Droplet transport and coalescence kinetics in emulsions subjected to acoustic fields; Ultrasonics 46, pp. 289-302 (2007). |
Ponomarenko et al.; Density of states and zero Landau level probed through capacitance of graphene; Nature Nanotechnology Letters, Jul. 5, 2009; DOI: 10.1038/NNAN0.2009.177. |
Ryll et al.; Performance of Small-Scale CHO Perfusion Cultures Using an Acoustic Cell Filtration Device for Cell Retention: Characterization of Separation Efficiency and Impact of Perfusion on Product Quality; Biotechnology and Bioengineering; vol. 69; Iss. 4; pp. 440-449; Aug. 2000. |
Seymour et al, J. Chem. Edu., 1990, 67(9), p. 763, published Sep. 1990. |
Volpin et al.; Mesh simplification with smooth surface reconstruction; Computer-Aided Design; vol. 30; No. 11; 1998. |
Wang et al.; Retention and Viability Characteristics of Mammalian Cells in an Acoustically Driven Polymer Mesh; Biotechnol. Prog. 2004, pp. 384-387 (2004). |
Wicklund et al.; Ultrasonic Manipulation of Single Cells; Methods in Molecular Biology; vol. 853; pp. 1777-1196; 2012. |
Annex to Form PCT/ISA/206—Communication Relating to the Results of the Partial International Search Report, dated Jul. 18, 2013. |
European Search Report of European Application No. 11769474.5, dated Sep. 5, 2013. |
European Search Report of European Application No. 13760840.2, dated Feb. 4, 2016. |
European Search Report of European Application No. 13721179.3 dated Feb. 23, 2016. |
International Search Report and Written Opinion dated Dec. 20, 2011, for corresponding PCT application No. PCT/US2011/032181. |
International Search Report and Written Opinion dated Feb. 27, 2012, for PCT application No. PCT/US2011/040787. |
International Search Report and Written Opinion of International Application No. PCT/US2012/051804 dated Nov. 16, 2012. |
International Search Report and Written Opinion of International Application No. PCT/US2013/037404 dated Jun. 21, 2013. |
International Search Report and Written Opinion of International Application No. PCT/US2013/032705 dated Jul. 26, 2013. |
International Search Report and Written Opinion of International Application No. PCT/US2013/050729 dated Sep. 25, 2013. |
International Search Report dated Feb. 18, 2014 in corresponding PCT Application No. PCT/US2013/059640. |
International Search Report for corresponding PCT Application Serial No. PCT/US2014/015382 dated May 6, 2014. |
International Search Report for PCT/US2014/035557 dated Aug. 27, 2014. |
International Search Report for PCT/US2014/043930 dated Oct. 22, 2014. |
International Search Report for PCT/US2014/046412 dated Oct. 27, 2014. |
International Search Report for PCT/US2014/064088 dated Jan. 30, 2015. |
Extended European Search Report for Application No. EP 12833859.7 dated Mar. 20, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/010595 dated Apr. 15, 2015. |
International Search Report for PCT/US2015/019755 dated May 4, 2015. |
International Search Report dated Jul. 30, 2015 for International Application No. PCT/US2015/030009. |
International Search Report for PCT/US2015/039125 dated Sep. 30, 2015. |
International Search Report and Written Opinion for PCT Application Serial No. PCT/US2015/053200 dated Dec. 28, 2015. |
European Search Report of European Application No. 11796470.0 dated Jan. 5, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2015/066884, dated Mar. 22, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/024082 dated Jun. 27, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/044586 dated Oct. 21, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/031357 dated Jul. 26, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2015/024365 dated Oct. 13, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/041664 dated Oct. 18, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/049088 dated Nov. 28, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/050415 dated Nov. 28, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/037104 dated Dec. 16, 2016. |
Phys. Org. “Engineers develop revolutionary nanotech water desalination membrane.” Nov. 6, 2006. http://phys.org/news82047372.html. |
“Proceedings of the Acoustics 2012 Nantes Conference,” Apr. 23-27, 2012, Nantes, France, pp. 278-282. |
Sony New Release: <http://www.sony.net/SonyInfo/News/Press/201010/10-137E/index.html>. |
Number | Date | Country | |
---|---|---|---|
20170218323 A1 | Aug 2017 | US |
Number | Date | Country | |
---|---|---|---|
62286984 | Jan 2016 | US | |
62256952 | Nov 2015 | US | |
62243211 | Oct 2015 | US | |
62211057 | Aug 2015 | US | |
62093491 | Dec 2014 | US | |
61761717 | Feb 2013 | US | |
61708641 | Oct 2012 | US | |
61754792 | Jan 2013 | US | |
61708641 | Oct 2012 | US | |
61611159 | Mar 2012 | US | |
61611240 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15139248 | Apr 2016 | US |
Child | 15417172 | US | |
Parent | 14975307 | Dec 2015 | US |
Child | 15139248 | US | |
Parent | 14175766 | Feb 2014 | US |
Child | 14975307 | US | |
Parent | 14026413 | Sep 2013 | US |
Child | 14175766 | US | |
Parent | 13844754 | Mar 2013 | US |
Child | 14026413 | US |